| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.0063 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |